Skip to content
2000
Volume 22, Issue 1
  • ISSN: 2666-0822
  • E-ISSN: 2666-0830

Abstract

Objective

This review examines the efficacy of psychological interventions in the management of Irritable Bowel Syndrome (IBS).

Methods

In the current study, a comprehensive analysis of the existing literature, covering case studies and clinical trials, compiled from Google Scholar, Sci-Hub, and PubMed, was performed. The research focused on the complex interplay between psychological factors and irritable bowel syndrome (IBS), particularly the ways in which mental and emotional states can impact IBS symptoms and the effects of behavioral therapy on IBS management.

Results

The efficacy of psychological therapies in addressing irritable bowel syndrome (IBS) has proven effective. Cognitive Behavioral Therapy (CBT) treats pain perception and gastrointestinal symptoms, whereas gut-directed hypnotherapy is known for lowering symptoms and enhancing quality of life. Mindfulness-based stress reduction and relaxation practices are effective for stress management, but their availability is restricted. Personalized treatment strategies tailored to individual requirements are vital for enhancing the advantages of these therapies in IBS management.

Conclusion

Psychological interventions provide a valuable and effective approach to managing IBS. CBT, gut-directed hypnotherapy, and MBSR have been shown to significantly improve symptoms and quality of life. Future research should focus on improving these therapies to better address individual symptoms and brain-gut connections. Incorporating neurological and neurophysiological approaches may improve understanding and lead to more tailored treatments. Expanding accessibility and encouraging collaboration between healthcare providers and mental health specialists will be vital for optimizing IBS management and improving patient outcomes.

Loading

Article metrics loading...

/content/journals/cprr/10.2174/0126660822325668241118073750
2025-01-03
2026-03-01
Loading full text...

Full text loading...

References

  1. BoyceP.M. KoloskiN.A. TalleyN.J. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?Am. J. Gastroenterol.200095113176318310.1111/j.1572‑0241.2000.03197.x11095338
    [Google Scholar]
  2. HilliläM.T. FärkkiläM.A. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population.Aliment. Pharmacol. Ther.200420333934510.1111/j.1365‑2036.2004.02034.x15274671
    [Google Scholar]
  3. HunginA.P.S. WhorwellP.J. TackJ. MearinF. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects.Aliment. Pharmacol. Ther.200317564365010.1046/j.1365‑2036.2003.01456.x12641512
    [Google Scholar]
  4. StaudacherH.M. BlackC.J. TeasdaleS.B. Mikocka-WalusA. KeeferL. Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management.Nat. Rev. Gastroenterol. Hepatol.202320958259610.1038/s41575‑023‑00794‑z37268741
    [Google Scholar]
  5. HellströmP.M. Pathophysiology of the irritable bowel syndrome – Reflections of today.Best Pract. Res. Clin. Gastroenterol.201940-4110162010.1016/j.bpg.2019.05.00731594651
    [Google Scholar]
  6. CamilleriM. KatzkaD.A. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.Am. J. Physiol. Gastrointest. Liver Physiol.201230210G1075G108410.1152/ajpgi.00537.201122403795
    [Google Scholar]
  7. CamilleriM. BuénoL. AndresenV. De PontiF. ChoiM.G. LemboA. Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders.Gastroenterology2016150613191331.e2010.1053/j.gastro.2016.02.029
    [Google Scholar]
  8. PosserudI. AgerforzP. EkmanR. BjörnssonE.S. AbrahamssonH. SimrénM. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.Gut20045381102110810.1136/gut.2003.01796215247175
    [Google Scholar]
  9. BarbaraG. CremonC. CariniG. BellacosaL. ZecchiL. GiorgioR.D. CorinaldesiR. StanghelliniV. The immune system in irritable bowel syndrome.J. Neurogastroenterol. Motil.201117434935910.5056/jnm.2011.17.4.34922148103
    [Google Scholar]
  10. KimS.E. ChangL. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?Neurogastroenterol. Motil.2012241089591310.1111/j.1365‑2982.2012.01993.x22863120
    [Google Scholar]
  11. MulakA. BonazB. Irritable bowel syndrome: a model of the brain-gut interactions.Med. Sci. Monit.2004104RA55RA6215260348
    [Google Scholar]
  12. KonturekS.J. KonturekJ.W. PawlikT. BrzozowskiT. Brain-gut axis and its role in the control of food intake.J. Physiol. Pharmacol.2004551 Pt 213715415082874
    [Google Scholar]
  13. MayerE.A. TillischK. The brain-gut axis in abdominal pain syndromes.Annu. Rev. Med.201162138139610.1146/annurev‑med‑012309‑10395821090962
    [Google Scholar]
  14. GrootJ. BijlsmaP. KalkerenA.V. KiliaanA. SaundersP. PerdueM. Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation.Ann. N. Y. Acad. Sci.2000915123724610.1111/j.1749‑6632.2000.tb05247.x11193581
    [Google Scholar]
  15. BonazB. SabateJ.M. [Brain-gut axis dysfunction].Gastroenterol. Clin. Biol.200933Suppl. 1S48S5810.1016/S0399‑8320(09)71525‑819303539
    [Google Scholar]
  16. DornS.D. PalssonO.S. ThiwanS.I.M. KanazawaM. ClarkW.C. van TilburgM.A.L. DrossmanD.A. ScarlettY. LevyR.L. RingelY. CrowellM.D. OldenK.W. WhiteheadW.E. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity.Gut20075691202120910.1136/gut.2006.11739017483191
    [Google Scholar]
  17. CeuleersH. Van SpaendonkH. HanningN. HeirbautJ. LambeirA.M. JoossensJ. AugustynsK. De ManJ.G. De MeesterI. De WinterB.Y. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.World J. Gastroenterol.20162247102751028610.3748/wjg.v22.i47.1027528058009
    [Google Scholar]
  18. DekelR. DrossmanD.A. SperberA.D. The use of psychotropic drugs in irritable bowel syndrome.Expert Opin. Investig. Drugs201322332933910.1517/13543784.2013.76120523316916
    [Google Scholar]
  19. ShahK. Ramos-GarciaM. BhavsarJ. LehrerP. Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis.Behav. Res. Ther.202012810346210.1016/j.brat.2019.10346232229334
    [Google Scholar]
  20. BanerjeeA. SarkhelS. DhaliG.K. PaulI. DasA. A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome.Indian J. Psychiatry202466214214710.4103/indianjpsychiatry.indianjpsychiatry_732_2338523769
    [Google Scholar]
  21. WhiteD.L. SavasL.S. DaciK. ElseragR. GrahamD.P. FitzgeraldS.J. SmithS.L. TanG. El-SeragH.B. Trauma history and risk of the irritable bowel syndrome in women veterans.Aliment. Pharmacol. Ther.201032455156110.1111/j.1365‑2036.2010.04387.x20528828
    [Google Scholar]
  22. BlanchardE.B. KeeferL. PayneA. TurnerS.M. GalovskiT.E. Early abuse, psychiatric diagnoses and irritable bowel syndrome.Behav. Res. Ther.200240328929810.1016/S0005‑7967(01)00057‑211863239
    [Google Scholar]
  23. QinH.Y. ChengC.W. TangX.D. BianZ.X. Impact of psychological stress on irritable bowel syndrome.World J. Gastroenterol.20142039141261413110.3748/wjg.v20.i39.1412625339801
    [Google Scholar]
  24. SinghP. AgnihotriA. PathakM.K. ShiraziA. TiwariR.P. SreenivasV. SagarR. MakhariaG.K. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center.J. Neurogastroenterol. Motil.201218332433110.5056/jnm.2012.18.3.32422837881
    [Google Scholar]
  25. MasandP.S. SousouA.J. GuptaS. KaplanD.S. Irritable bowel syndrome (IBS) and alcohol abuse or dependence.Am. J. Drug Alcohol Abuse199824351352110.3109/009529998090169139741950
    [Google Scholar]
  26. KarlingP. DanielssonÅ. AdolfssonR. NorrbackK. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.Neurogastroenterol. Motil.2007191189690410.1111/j.1365‑2982.2007.00967.x17973640
    [Google Scholar]
  27. SugayaN. YoshidaE. YasudaS. TochigiM. TakeiK. OhtaniT. OtowaT. MinatoT. UmekageT. SakanoY. ChenJ. ShimadaH. NomuraS. OkazakiY. KaiyaH. TaniiH. SasakiT. Irritable bowel syndrome, its cognition, anxiety sensitivity, and anticipatory anxiety in panic disorder patients.Psychiatry Clin. Neurosci.201367639740410.1111/pcn.1206923890055
    [Google Scholar]
  28. MayerE.A. CraskeM. NaliboffB.D. Depression, anxiety, and the gastrointestinal system.J. Clin. Psychiatry200162Suppl. 8283612108819
    [Google Scholar]
  29. LeeS. WuJ. MaY.L. TsangA. GuoW.J. SungJ. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.Aliment. Pharmacol. Ther.200930664365110.1111/j.1365‑2036.2009.04074.x19552631
    [Google Scholar]
  30. GuptaS. MasandP.S. KaplanD. BhandaryA. HendricksS. The relationship between schizophrenia and irritable bowel syndrome (IBS).Schizophr. Res.199723326526810.1016/S0920‑9964(96)00099‑09075306
    [Google Scholar]
  31. GarakaniA. WinT. VirkS. GuptaS. KaplanD. MasandP.S. Comorbidity of irritable bowel syndrome in psychiatric patients: a review.Am. J. Ther.2003101616710.1097/00045391‑200301000‑0001412522523
    [Google Scholar]
  32. DinanT.G. QuigleyE.M.M. AhmedS.M.M. ScullyP. O’BrienS. O’MahonyL. O’MahonyS. ShanahanF. KeelingP.W.N. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?Gastroenterology2006130230431110.1053/j.gastro.2005.11.03316472586
    [Google Scholar]
  33. SudoN. ChidaY. AibaY. SonodaJ. OyamaN. YuX.N. KuboC. KogaY. Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice.J. Physiol.2004558126327510.1113/jphysiol.2004.06338815133062
    [Google Scholar]
  34. RheeS.H. PothoulakisC. MayerE.A. Principles and clinical implications of the brain–gut–enteric microbiota axis.Nat. Rev. Gastroenterol. Hepatol.20096530631410.1038/nrgastro.2009.3519404271
    [Google Scholar]
  35. KiliaanA.J. SaundersP.R. BijlsmaP.B. BerinM.C. TaminiauJ.A. GrootJ.A. PerdueM.H. Stress stimulates transepithelial macromolecular uptake in rat jejunum.Am. J. Physiol.19982755G1037G10449815034
    [Google Scholar]
  36. DemaudeJ. Salvador-CartierC. FioramontiJ. FerrierL. BuenoL. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction.Gut200655565566110.1136/gut.2005.07867516299034
    [Google Scholar]
  37. MorN. HaranD. Cognitive-behavioral therapy for depression.Isr. J. Psychiatry Relat. Sci.200946426927320635774
    [Google Scholar]
  38. HuntM.G. Cognitive-Behavioral therapy for irritable bowel syndrome.Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction: A Clinical Guide.Springer International Publishing201910.1007/978‑3‑030‑18218‑2_5
    [Google Scholar]
  39. HauserG. PletikosicS. TkalcicM. Cognitive behavioral approach to understanding irritable bowel syndrome.World J. Gastroenterol.201420226744675810.3748/wjg.v20.i22.674424944466
    [Google Scholar]
  40. LacknerJ.M. GudleskiG.D. KeeferL. KrasnerS.S. PowellC. KatzL.A. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.Clin. Gastroenterol. Hepatol.20108542643210.1016/j.cgh.2010.02.00720170751
    [Google Scholar]
  41. LacknerJ.M. KeeferL. JaccardJ. FirthR. BrennerD. BrattenJ. DunlapL.J. MaC. ByroadsM. IBSOS Research Group The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.Contemp. Clin. Trials20123361293131010.1016/j.cct.2012.07.01322846389
    [Google Scholar]
  42. HuntM.G. MoshierS. MilonovaM. Brief cognitive-behavioral internet therapy for irritable bowel syndrome.Behav. Res. Ther.200947979780210.1016/j.brat.2009.05.00219570525
    [Google Scholar]
  43. Moss-MorrisR. McAlpineL. DidsburyL.P. SpenceM.J. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.Psychol. Med.2010401859410.1017/S003329170999019519531276
    [Google Scholar]
  44. Van DulmenA.M. FennisJ.F.M. BleijenbergG. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up.Psychosom. Med.199658550851410.1097/00006842‑199609000‑000138902902
    [Google Scholar]
  45. DrossmanD.A. TonerB.B. WhiteheadW.E. DiamantN.E. DaltonC.B. DuncanS. EmmottS. ProffittV. AkmanD. FruscianteK. LeT. MeyerK. BradshawB. MikulaK. MorrisC.B. BlackmanC.J. HuY. JiaH. LiJ.Z. KochG.G. BangdiwalaS.I. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).Gastroenterology20031251193110.1016/S0016‑5085(03)00669‑312851867
    [Google Scholar]
  46. JonesM. KoloskiN. BoyceP. TalleyN.J. Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS.J. Psychosom. Res.201170327828510.1016/j.jpsychores.2010.10.00421334499
    [Google Scholar]
  47. EverittH. LandauS. LittleP. BishopF.L. McCroneP. O’ReillyG. ColemanN. LoganR. ChalderT. Moss-MorrisR. ACTIB trial team Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.BMJ Open201557e00862210.1136/bmjopen‑2015‑00862226179651
    [Google Scholar]
  48. Surdea-BlagaT. BabanA. NedelcuL. DumitrascuD.L. Psychological Interventions for Irritable Bowel Syndrome.J. Gastrointestin. Liver Dis.201625335936610.15403/jgld.2014.1121.253.ibs27689201
    [Google Scholar]
  49. KassimM.A.K. PantaziA.C. NoriW. TutaL.A. BalasaA.L. MihaiC.M. MihaiL. FrecusC.E. LupuV.V. LupuA. AndruscaA. IorgaA.M. LitrinR.M. IonI. CiciuE. ChirilaS.I. ChisnoiuT. Non-pharmacological interventions for pain management in hemodialysis: A narrative review.J. Clin. Med.20231216539010.3390/jcm1216539037629432
    [Google Scholar]
  50. BonnertM. OlénO. LalouniM. BenningaM.A. BottaiM. EngelbrektssonJ. HedmanE. LenhardF. MelinB. SimrénM. VigerlandS. SerlachiusE. LjótssonB. Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: a randomized controlled trial.Am. J. Gastroenterol.2017112115216210.1038/ajg.2016.50327845338
    [Google Scholar]
  51. KennedyT. JonesR. DarnleyS. SeedP. WesselyS. ChalderT. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial.BMJ2005331751443510.1136/bmj.38545.505764.0616093252
    [Google Scholar]
  52. TkachukG.A. GraffL.A. MartinG.L. BernsteinC.N. Randomized controlled trial of cognitive–behavioral group therapy for irritable bowel syndrome in a medical setting.J. Clin. Psychol. Med. Settings2003101576910.1023/A:1022809914863
    [Google Scholar]
  53. WhorwellP.J. Review article: the history of hypnotherapy and its role in the irritable bowel syndrome.Aliment. Pharmacol. Ther.20052211-121061106710.1111/j.1365‑2036.2005.02697.x16305719
    [Google Scholar]
  54. GholamrezaeiA. ArdestaniS.K. EmamiM.H. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review.J. Altern. Complement. Med.200612651752710.1089/acm.2006.12.51716884342
    [Google Scholar]
  55. HarveyR.F. GunaryR.M. HintonR.A. BarryR.E. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome.Lancet1989333863542442510.1016/S0140‑6736(89)90013‑52563797
    [Google Scholar]
  56. ChiarioniG. VantiniI. De IorioF. BeniniL. Prokinetic effect of gut‐oriented hypnosis on gastric emptying.Aliment. Pharmacol. Ther.20062381241124910.1111/j.1365‑2036.2006.02881.x16611286
    [Google Scholar]
  57. WhorwellP.J. HoughtonL.A. TaylorE.E. MaxtonD.G. Physiological effects of emotion: assessment via hypnosis.Lancet19923408811697210.1016/0140‑6736(92)90394‑I1352012
    [Google Scholar]
  58. LeaR. HoughtonL.A. CalvertE.L. LarderS. GonsalkoraleW.M. WhelanV. RandlesJ. CooperP. CruickshanksP. MillerV. WhorwellP.J. Gut‐focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome.Aliment. Pharmacol. Ther.200317563564210.1046/j.1365‑2036.2003.01486.x12641511
    [Google Scholar]
  59. GonsalkoraleW.M. TonerB.B. WhorwellP.J. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.J. Psychosom. Res.200456327127810.1016/S0022‑3999(03)00076‑X15046962
    [Google Scholar]
  60. GonsalkoraleW.M. HoughtonL.A. WhorwellP.J. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.Am. J. Gastroenterol.200297495496110.1111/j.1572‑0241.2002.05615.x12003432
    [Google Scholar]
  61. RainvilleP. DuncanG.H. PriceD.D. CarrierB. BushnellM.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex.Science1997277532896897110.1126/science.277.5328.9689252330
    [Google Scholar]
  62. LowénM.B.O. MayerE.A. SjöbergM. TillischK. NaliboffB. LabusJ. LundbergP. StrömM. EngströmM. WalterS.A. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome.Aliment. Pharmacol. Ther.201337121184119710.1111/apt.1231923617618
    [Google Scholar]
  63. NoriW. KassimM.A.K. HelmiZ.R. PantaziA.C. BrezeanuD. BrezeanuA.M. PenciuR.C. SerbanescuL. Non-pharmacological pain management in labor: a systematic review.J. Clin. Med.20231223720310.3390/jcm1223720338068274
    [Google Scholar]
  64. WhorwellP.J. PriorA. FaragherE.B. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome.Lancet198432484141232123410.1016/S0140‑6736(84)92793‑46150275
    [Google Scholar]
  65. SimrénM. RingströmG. BjörnssonE.S. AbrahamssonH. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome.Psychosom. Med.200466223323810.1097/01.psy.0000116964.76529.6e15039508
    [Google Scholar]
  66. GaylordS.A. WhiteheadW.E. CobleR.S. FaurotK.R. PalssonO.S. GarlandE.L. FreyW. MannJ.D. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.BMC Complement. Altern. Med.2009912410.1186/1472‑6882‑9‑2419638214
    [Google Scholar]
  67. ZernickeK.A. CampbellT.S. BlusteinP.K. FungT.S. JohnsonJ.A. BaconS.L. CarlsonL.E. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial.Int. J. Behav. Med.201320338539610.1007/s12529‑012‑9241‑622618308
    [Google Scholar]
  68. GhandiF. SadeghiA. BakhtyariM. ImaniS. AbdiS. BanihashemS.S. Comparing the efficacy of mindfulness-based stress reduction therapy with emotion regulation treatment on quality of life and symptoms of irritable bowel syndrome.Iran. J. Psychiatry201813317518330319700
    [Google Scholar]
  69. GaylordS.A. PalssonO.S. GarlandE.L. FaurotK.R. CobleR.S. MannD.J. FreyW. LeniekK. WhiteheadW.E. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.Am. J. Gastroenterol.201110691678168810.1038/ajg.2011.18421691341
    [Google Scholar]
  70. FordA.C. LacyB.E. HarrisL.A. QuigleyE.M.M. MoayyediP. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis.Am. J. Gastroenterol.20191141213910.1038/s41395‑018‑0222‑530177784
    [Google Scholar]
  71. SvedlundJ. OttossonJ-O. SjödinI. DotevallG. Controlled study of psychotherapy in irritable bowel syndrome.Lancet1983322835058959210.1016/S0140‑6736(83)90678‑56136745
    [Google Scholar]
  72. HyphantisT. GuthrieE. TomensonB. CreedF. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome.Pain2009145119620310.1016/j.pain.2009.07.00519643544
    [Google Scholar]
  73. ShiraziM. AshtianiA. TabatabaeiS.K. AminiM. Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment.Arch. Med. Sci.20121112312910.5114/aoms.2012.2729222457686
    [Google Scholar]
  74. Heymann-MönnikesI. ArnoldR. FlorinI. HerdaC. MelfsenS. MönnikesH. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.Am. J. Gastroenterol.200095498199410.1016/S0002‑9270(00)00729‑210763948
    [Google Scholar]
  75. KenwrightM. McDonaldJ. TalbotJ. JanjuaK. Do symptoms of irritable bowel syndrome improve when patients receive cognitive behavioural therapy for co-morbid anxiety disorders in a primary care psychological therapy (IAPT) service?Behav. Cogn. Psychother.201745543344710.1017/S135246581700020028478779
    [Google Scholar]
  76. BlackC.J. ThakurE.R. HoughtonL.A. QuigleyE.M.M. MoayyediP. FordA.C. Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis.Gut20206981441145110.1136/gutjnl‑2020‑32119132276950
    [Google Scholar]
  77. HassanW.N.M. Al-kaabiM.M. AkramN.N. KassimM.A.K. PantaziA.C. Probiotics for inflammatory bowel disease; A deep dive into their impact on disease course and associated health risks.Curr. Med. Chem.202431304807482510.2174/010929867331486124042907235238693730
    [Google Scholar]
/content/journals/cprr/10.2174/0126660822325668241118073750
Loading
/content/journals/cprr/10.2174/0126660822325668241118073750
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test